Table 2.
Bioactive compounds against CNS disorders from native species of Bangladesh
| Species name | Active compounds | Mechanism of action | Ailments | References |
|---|---|---|---|---|
| Acorus calamus L. | α-Asarone, β-asarone | Acetylcholiesterase inhibitor | Alzheimer’s disease, memory loss | [284] |
| Bacopa monniera (L.) Wettst. | Bacoside A3, bacopaside II, bacopasaponin C, bacopaside X | Inhibits β-amyloid (Aβ) and fibrilation | Alzheimer’s disease, memory loss | [41] |
| Blumea balsamifera DC. | Blumpenes A, B, C, and D | Inhibition of NO | Alzheimer’s disease | [158] |
| Cannabis sativa L. | Δ9-Tetrahydrocannabinol | Inhibits β-amyloid | Alzheimer’s disease | [285] |
| Attenuates the motor coordination deficits and huntingtin aggregate | Huntington’s disease | [85] | ||
| Prevent neuronal damage | Parkinson’s disease | [286] | ||
| Cannabidiol | Reduces Aβ–induced neuroinflammation | Alzheimer’s disease | [287] | |
| Prevent neuronal damage | Parkinson’s disease | [286] | ||
| Centella asiatica (L.) Urb. | Asiatic acid | Prevent MPTP/p-induced neuronal cells loss | Parkinson’s disease | [47] |
| Citrus grandis Osbeck | 3,5,6,7,8,3′,4′-Heptamethoxyflavone | Induce activation of ERK1/2 and CREB in cultured neurons | Memory disorders, Alzheimer’s disease | [264] |
| Clerodendrum infortunatum L. (Syn:Clerodendrum viscosum Vent.) | Acteoside | Inhibits β-amyloid | Alzheimer’s disease, cognitive deficit | [82, 83] |
| Costus speciosus (J.Koenig) Sm. | Costunolide | Inhibition of NFkappaB and MAPKinase activation | Neuroinflammatory diseases | [167] |
| Curcuma longa L. | Curcumin, demethoxycurcumin, bis-demethoxycurcumin | Prevent acute neuroinflammation, mitochondrial dysfunction and apoptosis | Neuroinflammation and memory impairment, Parkinson’s disease | [50, 51] |
| Cyperus rotundus Vahl | α-Cyperone, terpinen-4-ol | Destabilization of microtubule fibers in brain | Brain inflammation | [61, 62] |
| Lantana camara L. | Ursolic acid stearoyl glucoside | Unknown | Anxiety | [272] |
| Nigella sativa L. | Thymoquinone | Inhibits β-amyloid | Alzheimer’s disease | [288] |
| Retrieved dopaminergic neurons | Parkinson’s disease | [257] | ||
| Oroxylum indicum (L.) Benth. | Apigenin, baicalein, baicalin, chrysin, hispidulin, oroxylin A | Induce neuronal differentiation | Disorder of nerve tissue development | [144] |
| Piper betel Blanco | Hydroxychavicol | Atenuate cytokines and both β- and γ-secretase | Cognitive dysfunction, Alzheimer’s disease | [243] |
| Piper cubeba L.f. | Cubebin | Acetylcholiesterase inhibitor | Cognitive dysfunction, Alzheimer’s disease | [244] |
| Piper retrofractum Vahl | Piperodione | Nerve growth factor (NGF) potentiation | Neurodegenerative diseases, Alzheimer’s disease | [247] |
| Santalum album L. | α-Santalol, β-santalol | Sedation | Anxiety | [289] |
| Solanum indicum L. | Seasmol | Protect blood–brain barrier breakdown | Alzheimer’s disease and multiple sclerosis | [267] |
| Withania somnifera (L.) Dunal | Withanolide A, withanone, withaferin A, withanoside IV, sitoindoside VII, sitoindoside VIII, sitoindoside IX, sitoindoside X | Prevent loss of axons, dendrites, and synapses; neuroprotection, enhance antioxidant enzymes | Alzheimer’s disease | [73, 78, 80, 290] |
| Ziziphus mauritiana Lam. (Syn: Ziziphus jujube Mill.) | cis-9,10Octadecenamide, jujuboside-A, jujuboside-B | Increase cholinesterase and cholinesterasetrasferase activity, GABA-binding modulation | Epilepsy, depression, memory loss | [259, 260, 291] |
CREB cAMP response element-binding protein; MAPKinase mitogen-activated protein kinases; ERK1/2 extracellular signal-regulated kinase-1/2; NFkappaB nuclear factor kappa of activated B cells